Trials / Sponsors / Pharmacyclics Switzerland GmbH
Pharmacyclics Switzerland GmbH
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell | Phase 4 | 2017-05-22 |
| Completed | Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Ref Multiple Myeloma | Phase 2 | 2016-09-20 |